CA-PACKETFABRIC
9.2.2021 15:02:09 CET | Business Wire | Press release
PacketFabric , an innovator of on-demand connectivity for enterprise customers to the secure private internet, today announced a strategic partnership with Colt Technology Services, a leading provider of global high bandwidth connectivity solutions. This partnership sees Colt’s On Demand offering being directly integrated with PacketFabric’s Network-as-a-Service (NaaS) platform, initially enabling PacketFabric’s enterprise customers to benefit from real-time network connectivity to 100 key data center locations across Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210209005271/en/
PacketFabric’s global customer base can now create private, secure, low latency hybrid cloud and backbone connectivity in minutes, enabled via an API-based software defined interconnection with Colt. Colt’s On Demand platform is underpinned by the Colt IQ Network, which spans more than 29,000 on net buildings and 900 data centers globally, and will significantly increase the reach of PacketFabric’s advanced NaaS platform throughout Europe. Through this integration, PacketFabric’s enterprise customers will be able to benefit from a true SDN experience, which sees services being delivered in real-time via a portal, creating greater agility for the fast-paced business landscape of today.
“When we looked at our European expansion plans, it was clear that Colt was the right strategic partner for PacketFabric,” said Jezzibell Gilmore, PacketFabric Co-founder and Chief Commercial Officer. “Not only is Colt an innovator and pioneer in connectivity services, but they lead the telecom industry in diversity and inclusion. As a women-founded start-up, we are passionate how Colt CEO Keri Gilder has been a champion for women in the telecom and tech industry—so this partnership is personally meaningful for me and my co-founder Anna Claiborne.”
“Colt strives to transform the way the world works through the power of connectivity and this collaboration with PacketFabric will offer enterprise customers the agility and flexibility they need to take on the business challenges of today,” said Keri Gilder, CEO of Colt. “At Colt, we don’t just want to transform how networks are provisioned, we also believe in changing how this sector is viewed and the voices that are heard in it. I am passionate about championing women and I am proud to be partnering with a company created and led by women. I see this collaboration being just an example of how we are innovating and delivering the networks of tomorrow for customers globally.”
“Structure Research’s Global Data Center and Colocation Report reported that EU interconnection will continue to populate and expand, and the market will see significant expansion which bodes well for our partnership and joint enterprise customers,” said Anna Claiborne, PacketFabric Co-founder and SVP Product and Engineering.
The Colt IQ Network connects data centers across Europe, Asia and North America’s largest business hubs. PacketFabric’s Network-as-a-Service platform orchestrates and guarantees connectivity between colocation facilities, clouds, and offers private network interconnection. PacketFabric was recently awarded the “2020 Fierce Telecom Innovation Award for Cloud Services,” a “2020 Cool Vendor in Enhanced Internet Services and Cloud Connectivity” by Gartner and one of the “10 Hottest Networking Startups of 2020” by CRN.
About PacketFabric
PacketFabric redefines how the enterprise moves data by automating network connectivity services. Leveraging an entirely automated SDN-based network architecture and the latest in optical and packet switching technology, PacketFabric enables dynamic, real-time connectivity services between more than hundreds of premier colocation facilities across many global markets. The PacketFabric Network-as-a-Service (NaaS) platform delivers simple, cost-effective, and scalable network deployment via its advanced Application Program Interface (API) and web portal. PacketFabric was named the “2020 Fierce Telecom Innovation Award for Cloud Services,” one of the “10 Hottest Networking Startups of 2020” by CRN and a “2020 Cool Vendor in Enhanced Internet Services and Cloud Connectivity” by Gartner. PacketFabric investors include NantWorks and Digital Alpha Advisors. For more information, visit packetfabric.com .
About Colt
Colt strives to transform the way the world works through the power of connectivity, taking what’s always been in its DNA to enable customers’ success. The Colt IQ Network connects more than 900+ data centers and over 29,000 on net buildings across Europe, Asia and North America’s largest business hubs.
Colt understands today’s shifting connectivity requirements and provides agile, on-demand and secure high bandwidth networking and voice solutions to ensure enterprises can thrive. Customers include data-intensive organizations spanning over 210 cities in more than 30 countries. Colt is a recognized innovator and pioneer in Software Defined Networks (SDN) and Network Function Virtualization (NFV). Privately owned, Colt is one of the most financially sound companies in the sector, and because of this, it’s able to put its customers’ needs at its core. For more information, please visit www.colt.net .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005271/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom